Charge Syndrome
Total Page:16
File Type:pdf, Size:1020Kb

Load more
Recommended publications
-
Reportable BD Tables Apr2019.Pdf
April 2019 Georgia Department of Public Health | Division of Health Protection | Maternal and Child Health Epidemiology Unit Reportable Birth Defects with ICD-10-CM Codes Reportable Birth Defects in Georgia with ICD-10-CM Diagnosis Codes Table D.1 Brain Malformations and Neural Tube Defects ICD-10-CM Diagnosis Codes Birth Defect ICD-10-CM 1. Brain Malformations and Neural Tube Defects Q00-Q05, Q07 Anencephaly Q00.0 Craniorachischisis Q00.1 Iniencephaly Q00.2 Frontal encephalocele Q01.0 Nasofrontal encephalocele Q01.1 Occipital encephalocele Q01.2 Encephalocele of other sites Q01.8 Encephalocele, unspecified Q01.9 Microcephaly Q02 Malformations of aqueduct of Sylvius Q03.0 Atresia of foramina of Magendie and Luschka (including Dandy-Walker) Q03.1 Other congenital hydrocephalus (including obstructive hydrocephaly) Q03.8 Congenital hydrocephalus, unspecified Q03.9 Congenital malformations of corpus callosum Q04.0 Arhinencephaly Q04.1 Holoprosencephaly Q04.2 Other reduction deformities of brain Q04.3 Septo-optic dysplasia of brain Q04.4 Congenital cerebral cyst (porencephaly, schizencephaly) Q04.6 Other specified congenital malformations of brain (including ventriculomegaly) Q04.8 Congenital malformation of brain, unspecified Q04.9 Cervical spina bifida with hydrocephalus Q05.0 Thoracic spina bifida with hydrocephalus Q05.1 Lumbar spina bifida with hydrocephalus Q05.2 Sacral spina bifida with hydrocephalus Q05.3 Unspecified spina bifida with hydrocephalus Q05.4 Cervical spina bifida without hydrocephalus Q05.5 Thoracic spina bifida without -
MICHIGAN BIRTH DEFECTS REGISTRY Cytogenetics Laboratory Reporting Instructions 2002
MICHIGAN BIRTH DEFECTS REGISTRY Cytogenetics Laboratory Reporting Instructions 2002 Michigan Department of Community Health Community Public Health Agency and Center for Health Statistics 3423 N. Martin Luther King Jr. Blvd. P. O. Box 30691 Lansing, Michigan 48909 Michigan Department of Community Health James K. Haveman, Jr., Director B-274a (March, 2002) Authority: P.A. 236 of 1988 BIRTH DEFECTS REGISTRY MICHIGAN DEPARTMENT OF COMMUNITY HEALTH BIRTH DEFECTS REGISTRY STAFF The Michigan Birth Defects Registry staff prepared this manual to provide the information needed to submit reports. The manual contains copies of the legislation mandating the Registry, the Rules for reporting birth defects, information about reportable and non reportable birth defects, and methods of reporting. Changes in the manual will be sent to each hospital contact to assist in complete and accurate reporting. We are interested in your comments about the manual and any suggestions about information you would like to receive. The Michigan Birth Defects Registry is located in the Office of the State Registrar and Division of Health Statistics. Registry staff can be reached at the following address: Michigan Birth Defects Registry 3423 N. Martin Luther King Jr. Blvd. P.O. Box 30691 Lansing MI 48909 Telephone number (517) 335-8678 FAX (517) 335-9513 FOR ASSISTANCE WITH SPECIFIC QUESTIONS PLEASE CONTACT Glenn E. Copeland (517) 335-8677 Cytogenetics Laboratory Reporting Instructions I. INTRODUCTION This manual provides detailed instructions on the proper reporting of diagnosed birth defects by cytogenetics laboratories. A report is required from cytogenetics laboratories whenever a reportable condition is diagnosed for patients under the age of two years. -
Statistical Analysis Plan
Cover Page for Statistical Analysis Plan Sponsor name: Novo Nordisk A/S NCT number NCT03061214 Sponsor trial ID: NN9535-4114 Official title of study: SUSTAINTM CHINA - Efficacy and safety of semaglutide once-weekly versus sitagliptin once-daily as add-on to metformin in subjects with type 2 diabetes Document date: 22 August 2019 Semaglutide s.c (Ozempic®) Date: 22 August 2019 Novo Nordisk Trial ID: NN9535-4114 Version: 1.0 CONFIDENTIAL Clinical Trial Report Status: Final Appendix 16.1.9 16.1.9 Documentation of statistical methods List of contents Statistical analysis plan...................................................................................................................... /LQN Statistical documentation................................................................................................................... /LQN Redacted VWDWLVWLFDODQDO\VLVSODQ Includes redaction of personal identifiable information only. Statistical Analysis Plan Date: 28 May 2019 Novo Nordisk Trial ID: NN9535-4114 Version: 1.0 CONFIDENTIAL UTN:U1111-1149-0432 Status: Final EudraCT No.:NA Page: 1 of 30 Statistical Analysis Plan Trial ID: NN9535-4114 Efficacy and safety of semaglutide once-weekly versus sitagliptin once-daily as add-on to metformin in subjects with type 2 diabetes Author Biostatistics Semaglutide s.c. This confidential document is the property of Novo Nordisk. No unpublished information contained herein may be disclosed without prior written approval from Novo Nordisk. Access to this document must be restricted to relevant parties.This -
November 2000
Vol.XVIII No. 3 NOVEMBER 2000 Scientific Journal of MEDICAL & VISION RESEARCH FOUNDATIONS 18, COLLEGE ROAD, CHENNAI - 600 006, INDIA Presurgical photograph taken at 28 days of life Age 13 months after skin grafting,showing no showing complete left cryptophthalmos. adhesions and good cosmetic outcome. Editorial Perspective — Treatment of Malignant Melanoma of Choroid — Mahesh P Shanmugam Prepucial Skin Graft for Fornicial and Socket Reconstruction in Complete Cryptophthalmos with Congenital Cystic Eye - A Case Report — Nirmala Subramanian, Surbhit Choudhry and Lakshmi Mahesh Detection of Cytomegalovirus (CMV) from Ocular Fluid of Two Patients with Progressive Outer Retinal Necrosis (PORN) — Jyotirmay Biswas, Surbhit Choudhry, K Priya and Lingam Gopal Unilateral Neuroretinitis following Chicken Pox - Report of a Case — Sumeet Chopra, Jyotirmay Biswas, Sudha K Ganesh and Satya Karna Human Genome Project: A Medical Revolution — G Kumaramanickavel Yeast - a Valuable tool for differential diagnosis of glycosuria and galactosuira — S. Ramakrishnan, K.N. Sulochana, R. Punitham and S.B. Vasanthi Last Page — Literature search on the Internet — Rajesh Fogla Editorial The event of this year, some dub it as that of the century _ the unraveling of the Human Genome finds a mention in this issue of Insight also. Dr. Kumaramanickavel has lucidly written about the implications of this discovery to Medicine and in particular Ophthalmology. Scientists especially the Genetic scientists predict the end of the scalpel and the pill. He has also introduced a new term _ Predictive Medicine. The concept is interesting _ predict the onset of the disease and annul it before it occurs. No doubt the darker side of this technology is foreboding to think of,but as Dr. -
Ophthalmic Ultrasound
Policy: 94047 Initial Effective Date: 10/20/1994 SUBJECT: Ophthalmic Ultrasound - A-scan ultrasound biometry - A-scan ultrasound - quantitative Annual Review Date: 11/11/2019 - B-scan ultrasound - Corneal pachymetry - Optical coherence biometry Last Revised Date: 11/11/2019 Definition: Ophthalmic ultrasonography, also known as echography, uses high-frequency sound waves (ultrasound) to produce images of ocular structures. The two main types of ultrasound used in ophthalmologic practice are A-Scan and B- scan. Ophthalmic ultrasound includes the following techniques: • A-scan ultrasound biometry: A-scan (time amplitude scan) ultrasound is a one-dimensional recording of the time taken for echoes to be reflected back to the transducer from surfaces of the eye (cornea, anterior lens, posterior lens, and retina) with vertical spikes that correspond to each tissue interface zone. A-scan ultrasound can be performed using either an applanation or immersion technique. The applanation technique is performed using a probe placed directly on the surface of the cornea. The immersion technique involves placing a saline filled scleral shell between the probe and the eye. Intraocular lens power calculation is the determination of the appropriate intraocular lens prior to cataract surgery. Standard intraocular lens power formulas use axial length and corneal curvature along with an intraocular lens constant to predict postoperative intraocular lens position. Precise ophthalmic biometry is essential to achieve the desired refractive outcome in cataract surgery. In A-scan biometry, axial length is the distance between the corneal and retinal echo. • Quantitative A-scan ultrasound: The other major use of A-scan ultrasonography is to characterize the internal structure of intraocular and orbital lesions. -
A Rare Case of Left Sided Anophthalmos with Congenital
86 P-ISSN 0972-0200 A Rare Case of Left Sided Anophthalmos with Congenital Cystic Eyeball with Right Sided Microphthalmos Umesh Harakuni, Smitha K.S., Nagbhushan Chougule, Madhura Patil, Preetha Sudhakaran, Maria Sequeira Linda Department of Ophthalmology, Jawaharlal Nehru Medical College, Belgaum, Karnataka, India Congenital cystic eye, also known as anophthalmos with cyst, is an extremely rare congenital anomaly, first described by Mann in 1939 with a prevalence of 3 per 1,00,000. Congenital micropthalmos is also a rare condition with prevalence rates of 1.4 - 3.5 per 10,000 births. The objective is to report a Summary case of a 19 year old male who was born to non-consanguineous marriage, presenting with left sided anophthalmos with right sided microphthalmos, with horizontal nystagmus and healed perforated Brief Communication corneal ulcer. Differential diagnosis include encephalocele, dermoid cyst, congenital cystic eye and tumors. Early visual rehabilitation is advised. Delhi J Ophthalmol 2019;29;86-88; Doi http://dx.doi.org/10.7869/djo.430 Keywords: Anophthalmos, Microphthalmos, Congenital cystic eyeball Case Report A 19 year old male patient presented to ophthalmology OPD with the complaints of diminution of vision in both eyes since birth. There was history of fever during the first trimester of pregnancy for which the mother had taken some medication from a local doctor. There was no history of consanguineous marriage, other sibling was normal. No other chronic medical or systemic illness was present. Clinically, there was no evidence of systemic associations like facial defects, webbed hands, colobomatous lids, preauricular tags, hydrocephalus/ microcephaly, seizures or cleft lip. -
Proptosis – a Clinical Study Conducted in CMC Is a Bonafide Work by Dr
A CLINICAL STUDY OF PROPTOSIS – A CLINICAL STUDY CONDUCTED IN CMC DISSERTATION SUBMITTED TO The Tamilnadu Dr. M.G.R. Medical University In partial fulfillment of the regulations for the M.S. Degree Examination in Ophthalmology March 2007 CERTIFICATE I hereby certify that this dissertation entitled "Proptosis – A clinical Study conducted in CMC is a bonafide work by Dr. S. Amudhavadivu during the period from June 2004 to September 2006 in Coimbatore Medical College, Coimbatore under my guidance and supervision. The conclusions reached in this study are her own. I have great pleasure in forwarding it to the Tamilnadu Dr. MGR Medical University. Place : Coimbatore Date : Head of the Institution Head of the Department Dean Coimbatore Medical College Hospital, Coimbatore – 641 018. ACKNOWLEDGEMENT I express my sincere thanks to Dr. T.P. Kalaniti, the Dean of Coimbatore Medical College, and the Vice Principal Dr. Indra Pranesh for permitting me to conduct this study. I wish to express my deepest gratitude to Dr. V.R. Vijayaraghavan, professor and head of the Department of Ophthalmology, Coimbatore Medical College for helping me choose this interesting topic for my dissertation work. His valuable suggestions, constant encouragement and guidance went a long way towards helping me to complete this work. I express my Profound thanks to Dr. A. Rajendraprasad, Professor, Dept of Ophthalmology, CMC Hospital for his constant help to motivate to do this study. My immens thanks to Dr. K. Maragatham, reader in ophthalmology Coimbatore Medical College, for her invaluable skilled guidance and timely suggestion. I also thank Dr. V. Savithiri, Assistant Professor, Department of Ophthalmology, Coimbatore Medical College, for her support and timely help in structuring my study. -
Case Report Management of Congenital Clinical Anophthalmos with Orbital Cyst: a Kinshasa Case Report
Hindawi Case Reports in Ophthalmological Medicine Volume 2018, Article ID 5010915, 6 pages https://doi.org/10.1155/2018/5010915 Case Report Management of Congenital Clinical Anophthalmos with Orbital Cyst: A Kinshasa Case Report Thomas Stahnke ,1 Andreas Erbersdobler ,2 Steffi Knappe,1 Rudolf F. Guthoff,1 and Ngoy J. Kilangalanga3 1 Department of Ophthalmology, Rostock University Medical Center, Doberaner Straße 140, 18057 Rostock, Germany 2Institute of Pathology, Rostock University Medical Center, Strempelstr. 14, 18055 Rostock, Germany 3Eye Department, Hospital Saint Joseph, 322 Limete/Kinshasa, Democratic Republic of the Congo Correspondence should be addressed to Tomas Stahnke; [email protected] Received 29 June 2018; Accepted 17 September 2018; Published 9 October 2018 Academic Editor: Takaaki Hayashi Copyright © 2018 Tomas Stahnke et al. Tis is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. An early developmental lack of the optic vesicle can result in congenital anophthalmia, defned as a complete absence of the eye, which can be distinguished from congenital microphthalmos, where ocular rudiments are present. Here, a rare pediatric case of congenital clinical anophthalmos with orbital cyst in the lef orbit is reported. Te patient was a 14-month-old girl with no other congenital defects who underwent surgical and prothetic management in St. Joseph’sHospital Kinshasa, Democratic Republic of the Congo (DRC). Surgery was carried out under general anesthesia. Te cyst was punctured and its wall fully excised. Near the orbital apex pigmented elements representing iris, ciliary body, and choroidal or retinal remnants were found. -
CSHCS Qualifying Diagnoses Effective 01/01/2021
CSHCS Qualifying Diagnoses Effective 01/01/2021 Medical Review ICD-10 Code Description Period Code End Date A1854 Tuberculous iridocyclitis 2 A507 Late congenital syphilis, unspecified 5 A925 Zika virus disease 2 B20 Human immunodeficiency virus [HIV] disease 5 B259 Cytomegaloviral disease, unspecified 5 B393 Disseminated histoplasmosis capsulati 2 B399 Histoplasmosis, unspecified 2 B900 Sequelae of central nervous system tuberculosis 5 B902 Sequelae of tuberculosis of bones and joints 3 B909 Sequelae of respiratory and unspecified tuberculosis 3 B91 Sequelae of poliomyelitis 5 B941 Sequelae of viral encephalitis 5 B942 Sequelae of viral hepatitis 2 B948 Sequelae of other specified infectious and parasitic diseases 2 C029 Malignant neoplasm of tongue, unspecified 5 C039 Malignant neoplasm of gum, unspecified 5 C051 Malignant neoplasm of soft palate 5 C080 Malignant neoplasm of submandibular gland 5 C089 Malignant neoplasm of major salivary gland, unspecified 5 C118 Malignant neoplasm of overlapping sites of nasopharynx 5 C119 Malignant neoplasm of nasopharynx, unspecified 5 C169 Malignant neoplasm of stomach, unspecified 5 C179 Malignant neoplasm of small intestine, unspecified 5 C188 Malignant neoplasm of overlapping sites of colon 5 C189 Malignant neoplasm of colon, unspecified 5 C19 Malignant neoplasm of rectosigmoid junction 5 C210 Malignant neoplasm of anus, unspecified 5 C220 Liver cell carcinoma 5 C222 Hepatoblastoma 5 C223 Angiosarcoma of liver 5 C224 Other sarcomas of liver 5 C227 Other specified carcinomas of liver 5 C228 Malignant -
1. Einleitung
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Publikationsserver der RWTH Aachen University Chromosomenanomalien und multiple systemische Fehlbildungen in SNOMED (Kapitel D 4) und in der ICD 10 (Kapitel XVII) – ein kritischer Vergleich und Vorschläge zu einer deutschen Version Von der Medizinischen Fakultät der Rheinisch - Westfälischen Technischen Hochschule Aachen zur Erlangung des akademischen Grades eines Doktors der Medizin genehmigte Dissertation vorgelegt von Ingrid Maria Blum geb. Schüller aus Mayen Diese Dissertation ist auf den Internetseiten der Hochschulbibliothek online verfügbar Berichter: Herr Universitätsprofessor Dr. med. Dipl.-Math. R. Repges Herr Universitätsprofessor Dr. med. Ch. Mittermayer Tag der mündlichen Prüfung: 10. April 2001 1. INHALTSVERZEICHNIS Seite 2 2. EINLEITUNG Seite 3 3. AUFGABENSTELLUNG UND METHODEN Seite 8 4. ÜBERSETZUNG Seite 10 5. DISKUSSION Seite 148 6. LITERATURVERZEICHNIS Seite 152 2 1. Einleitung In der modernen Zivilisation ist aufgrund der ansteigenden Datenmenge in allen Wissensbereichen eine umfassende Dokumentation mit standardisierten Mitteln unausweichlich. Deshalb muß auch in der heutigen Medizin die Menge und Vielfalt an Informationen systematisch katalogisiert werden, um eine nationale und auch internationale Nutzung zu erreichen. Eine strukturierte Datenerfassung bietet folgende Vorteile: - Sicherung von Daten, Befunden und Therapien des einzelnen Patienten. - Kommunikation und Kooperation zwischen verschiedenen Fachdisziplinen unter der Prämisse der Optimierung eines Behandlungskonzeptes. - Im Rahmen von Wissenschaft und Forschung können einzelfallübergreifend die erhobenen Datensätze für die Optimierung und Qualitätssicherung des medizinischen Standards genutzt werden. - Eine standardisierte Dokumentation ermöglicht die Kooperation und Interaktion auf internationalem Niveau. - Schaffung einer fundierten Grundlage für juristische Verfahren. - Bildung einer Orientierungshilfe für die Kostenrechnungsanalyse und Budgetierung für medizinische Einrichtungen. -
Practical Ophthalmology
Ministry of Education and Science of Ukraine Sumy State University S. E. Lekishvili PRACTICAL OPHTHALMOLOGY Study guide Recommended by the Academic Council of Sumy State University Sumy Sumy State University 2019 УДК 617.7(075.8) L51 Reviewers: O. V. Olkhova – Candidate of Medical Sciences, Head of the Department of Clinical Disciplines of the Ivan Franko National University of Lviv, M. D. Board certified in Ophthalmology; L. V. Hrytsay – Candidate of Medical Sciences, Head of the Department of Eye Microsurgery of the Sumy Regional Clinical Hospital, chief ophthalmologist of the Sumy region, M. D. Board certified in Ophthalmology Recommended for publication by the Academic Council of Sumy State University as a study guide (minutes № 5 of 10.11.2016) Lekishvili S. E. L51 Practical Ophthalmology : study guide / S. E. Lekishvili. – Sumy : Sumy State University, 2019. – 392 p. ISBN 978-966-657-763-7 The study guide is intended to train students of higher medical educational institutions of the fourth level of accreditation on the specialty “Medicine”, interns, residents and masters. The guide is a new progressive step in teaching the discipline “Ophthalmology”. УДК 617.7(075.8) © Lekishvili S. E., 2019 ISBN 978-966-657-763-7 © Sumy State University, 2019 2 CONTENTS P. LIST OF ABBREVIATIONS ………………………………… 4 TOPIC 1. OCULAR ANATOMY AND PHYSIOLOGY ……. 7 TOPIC 2. EYE EXAMINATION …………………………….. 45 TOPIC 3. REFRACTION AND ACCOMMODATION ……... 56 TOPIC 4. DISEASES OF EYELIDS AND ORBIT ………….. 78 TOPIC 5. DISEASES OF LACRIMAL SYSTEM …………... 106 TOPIC 6. STRABISMUS AND NYSTAGMUS …………….. 118 TOPIC 7. DISEASES OF THE CONJUNCTIVA ……………. 130 TOPIC 8. DISEASES OF THE CORNEA AND SCLERA …. -
Anterior Segment Photography with Fluorescein Angiography Reference Number: CP.VP.67 Coding Implications Last Review Date: 12/2020 Revision Log
Clinical Policy: Anterior Segment Photography with Fluorescein Angiography Reference Number: CP.VP.67 Coding Implications Last Review Date: 12/2020 Revision Log See Important Reminder at the end of this policy for important regulatory and legal information. Description Anterior segment photography with fluorescein angiography is performed to examine the iris. This procedure includes fluorescein angiography; which is for detection of abnormalities of retinal blood vessels. This policy describes the medical necessity requirements for anterior segment photography with fluorescein angiography. Policy/Criteria I. It is the policy of health plans affiliated with Centene Corporation® (Centene) that anterior segment imaging with fluorescein angiography is medically necessary for the following indications: A. Rubeosis iridis B. Neovascular glaucoma C. Diabetic retinopathy D. Retinal vein occlusion E. Uveitis F. Iris cyst G. Iris neoplasm H. Anterior segment ischemia I. Iris trauma or injury, including damage secondary to surgery Background Fluorescein angiography reveals information about the type, and thereby about the probable malignancy of iris tumors. In cases of iris cysts, angiography allows the differential diagnosis between congenital cysts and epithelial downgrowth cysts, in which a surgical treatment for the latter is absolutely necessary. Further indications for fluorescein angiography of the iris are neovascularization of the iris (rubeosis iridis), degenerative diseases, and anomalies of iris vessel formation. In these cases fluorescein angiography permits the diagnosis or differential diagnosis as well as follow-up. Neovascularization of the iris and angle may occur in response to retinal ischemia, uveitis, trauma, and radiation. Of these conditions, retinal ischemia due to diabetic retinopathy is the most common cause of neovascular glaucoma.